Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis
Science Advances · 2025
DOI: 10.1126/sciadv.adt0795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Sangwook Oh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: B-Lymphocytes, Receptors, Cholinergic, Myasthenia Gravis, Autoantibodies. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
In acetylcholine receptor (AChR)–seropositive myasthenia gravis (MG), anti-AChR autoantibodies impair neuromuscular transmission and cause severe muscle weakness. MG therapies broadly suppress immune function, risking infections. We designed a chimeric autoantibody receptor (CAAR) expressing the 210–amino acid extracellular domain of the AChR α subunit (A210) linked to CD137-CD3ζ cytoplasmic domains to direct T cell cytotoxicity against anti-AChRα B cells. A210-CAART incorporating a CD8α transmembrane domain (TMD8α) showed functional but unstable surface expression, partially restored by inhibiting lysosomal degradation. A210-CAART with a CD28 TMD showed sustained surface expression, independent of TMD dimerization motifs. In a mouse xenograft model, A210.TMD8α-CAART demonstrated early control of anti-AChR B cell outgrowth but subsequent rebound and loss of surface CAAR expression, whereas A210.TMD28-CAART induced sustained surface CAAR expression and target cell elimination. This study demonstrates the importance of the CD28 TMD for CAAR stability and in vivo function, laying the groundwork for future development of precision cellular immunotherapy for AChR-MG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
- Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, CT, USA.
ORCID-Profile: Sangwook Oh, Kevin C O'Connor, Aimee S Payne
Förderung
- NIAID NIH HHS
Zitieren
APA
Oh, S., Khani-Habibabadi, F., O'Connor, K. C., & Payne, A. S. (2025). Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis. Science Advances. https://doi.org/10.1126/sciadv.adt0795
Vancouver
Oh S, Khani-Habibabadi F, O'Connor KC, Payne AS. Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis. Science Advances. 2025. doi:10.1126/sciadv.adt0795
BibTeX
@article{Oh2025,
author = {Oh, Sangwook and Khani-Habibabadi, Fatemeh and O'Connor, Kevin C and Payne, Aimee S},
title = {Composition and function of AChR chimeric autoantibody receptor T cells for antigen-specific B cell depletion in myasthenia gravis},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt0795}
}
EUVIMED